December 25, 2024 07:38 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Azerbaijan Airlines passenger plane enroute to Russia with over 70 people onboard crashes in Kazakhstan | Atishi will be arrested in fake case, claims Arvind Kejriwal after Delhi govt disowns health and women's schemes | Delhi govt departments disown Arvind Kejriwal's major poll promises, AAP chief reacts | 'Our nation will always be grateful to him': PM Modi writes article in tribute to Atal Bihari Vajpayee on his birth centenary | Syria: Christmas tree set on fire by suspected 'Islamists', Christians protest | Pakistan strikes TTP camps in Afghanistan, Taliban government claims civilians killed | Former home secy Ajay Kumar Bhalla appointed Manipur Guv amid ethnic violence resurgence | Five soldiers killed, several injured as Army truck falls into Poonch gorge | Allu Arjun quizzed by police in Pushpa 2 stampede case | Wanted Indian drug smuggler killed in the US
MSN Labs initiates Phase-III clinical trials for COVID-19 treatment drug

MSN Labs initiates Phase-III clinical trials for COVID-19 treatment drug

May 25, 2021, at 08:49 pm

Hyderabad/UNI: MSN Laboratories Private Limited, the front-runner in introducing various drugs in the treatment of COVID-19 and its complications, on Tuesday announced that it is initiating phase III clinical trials of ‘Molnupiravir’ capsules for the treatment of COVID-19 in India.